Williams Brinkley Ruth
SEC insider (Form 3/4/5 filer). CIK 0001344381. Director at Travere Therapeutics, Inc. (TVTX) and 1 other issuer. 7 reported Form 4/5 transactions since Sep 2024; latest on May 19, 2026. Located in AUSTIN, TX.
Companies Williams Brinkley Ruth has filed insider reports for
- Travere Therapeutics, Inc. (TVTX): Director
- Natera, Inc. (NTRA): Director
Williams Brinkley Ruth
CIK: 0001344381
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)7 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (7 total)
- May 19, 2026TVTX
Travere Therapeutics, Inc.
AwardDirect4K shares- - Apr 24, 2026NTRA
Natera, Inc.
AwardDirect86 shares- - Jan 30, 2026NTRA
Natera, Inc.
AwardDirect73 shares- - Oct 31, 2025NTRA
Natera, Inc.
AwardDirect97 shares- - Jul 25, 2025NTRA
Natera, Inc.
AwardDirect112 shares- - Jun 27, 2025NTRA
Natera, Inc.
AwardDirect2.1K shares- - May 15, 2025TVTX
Travere Therapeutics, Inc.
AwardDirect6.5K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| May 19, 2026 |  TVTX Travere Therapeutics, Inc. | Award | 4,000 | - | $0 | Direct |
| Apr 24, 2026 |  NTRA Natera, Inc. | Award | 86 | - | $0 | Direct |
| Jan 30, 2026 | NTRA Natera, Inc. | Award | 73 | - | $0 | Direct |
| Oct 31, 2025 | NTRA Natera, Inc. | Award | 97 | - | - | Direct |
| Jul 25, 2025 | NTRA Natera, Inc. | Award | 112 | - | - | Direct |
| Jun 27, 2025 | NTRA Natera, Inc. | Award | 2,143 | - | - | Direct |
| May 15, 2025 | TVTX Travere Therapeutics, Inc. | Award | 6,500 | - | - | Direct |
1-7 of 7 transactions